A0010 Survival outcomes with Lutetium-177-PSMA-617 in metastatic castration-resistant prostate cancer patient according to baseline tumor characteristics

European Urology 2026

View at publisher
Authors: Mike Wenzel, D.Q.C. Le, Carolin Siech, Benedikt Hoeh, Konrad Klimek, Christian Happel, Fred Saad C, Felix Preißer, Derya Tilki A, Markus Graefen, T. Steuber, T. Maurer
+5 more M.C. Kriegmair, Pierre I. Karakiewicz, Felix K.‐H. Chun, D. Groener, P. Mandel
DOI: 10.1016/s0302-2838(26)00078-3
Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research Radiopharmaceutical Chemistry and Applications Prostate Cancer Diagnosis and Treatment

Publication details

Journal / source
European Urology
Volume
89
Pages
S1–S1
Publication date
13 February 2026
Language
EN